At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Giuseppe Viale (European Institute of Oncology and University of Milan, Milan, Italy) discusses the opportunities and challenges of developing new agents for breast cancer treatment, including optimising the use of drugs that target genetically defined breast cancer and the integration of these approaches.
>